Question follow-through · 28631

Israeli Settlements: Sanctions

To ask the Secretary of State for Business, Innovation, Science and Trade, what assessment his Department has made of the potential impact of sanctions on companies involved in settlements in the West Bank on the medicines supply chain.

answeredDepartment for Business, Innovation, Science and Trade

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body
Department for Business, Innovation, Science and Trade
Tabled
9 Sept 2026
Target answer date
11 Sept 2026
Answer
16 Sept 2026 · 7 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

Votes on this topic

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

  1. 9 Sept 2026

    Question tabled

    To ask the Secretary of State for Business, Innovation, Science and Trade, what assessment his Department has made of the potential impact of sanctions on companies involved in settlements in the West Bank on the medicines supply chain.

  2. 11 Sept 2026

    Target answer date

    Date supplied by the official written-questions record.

  3. 16 Sept 2026

    Answer published

    The measures announced by the Foreign Secretary on 8 September will include restrictions on the import into the UK of goods originating in illegal settlements. These measures will be carefully designed to target trade with illegal settlements, while prote...

Open official record

Official data retrieved 1 Oct 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

No later same-department questions indexed.

This is an absence in covered public data, not evidence that no follow-up occurred elsewhere.